Invited Faculty

Mark Abelson
Dr Abelson is an Interventional Cardiologist in practice since 2000 after graduating from Wits University and the University of Cape Town.

He is currently based at Busamed Paardevlei Private Hospital, Somerset West, Cape Town. Dr Abelson is also an honorary lecturer at UCT.

Dr Abelson areas of interest are complex coronary interventions, carotid stents and acute stroke intervention, left atrial appendage closure (Amulet) and TAVI
Bala Pillay
Dr Pillay completed his undergraduate medical degree at the University of Natal in 1992 and following his internship subsequently obtained fellowships in general surgery and vascular surgery sub-specialty respectively. In 2018 he obtained his PhD on the “Clinical and histopathological profile of arterial aneurysms and other forms of microvascular disease in patients infected with HIV”. Dr Pillay is currently the clinical head of the Department of Vascular / Endovascular surgery at Inkosi Albert Luthuli Central Hospital in Durban and is also the director of the vascular endovascular programme as well.

Dr Pillay has an active participatory interest in all aspects of open and endovascular surgery. He has an honorary appointment as a clinical fellow in the department of general surgery at the University of Kwa-Zulu Natal. He is a willing participant in the teaching and training of undergraduate medical students, surgical registrars and vascular fellows including bedside teaching, zoom sessions, seminars, forums, workshops, mock exams and refresher courses. Dr Pillay is integrally involved in clinical service delivery, academia and research. He serves on the executive committee of the Vascular society of South Africa and chair’s the current board of vascular examiners. He has been engaged in the College of Medicine of South Africa both in his capacity as convenor / examiner for the past decade.

Dr Pillay has authored several articles nationally and internationally and is an external MMed. thesis examiner for most South African universities and serves on various institutional advisory committees. Dr Pillay has been a contributory author to South African guidelines on renal, peripheral arterial and carotid disease. In August 2022 he has chaired the guideline writing committee meeting on HIV vascular disease.
Colette Beukes
Colette Beukes graduated as a pharmacist from North West University (then PU for CHE) in 2004. With a keen interest in clinical pharmacy, completed my MSC (Med) in Pharmacotherapy at WITS in 2011.

She represented the South African Society of Clinical Pharmacists’ Pretoria branch EXCO for 4 years. Over the years Colette has presented international poster presentations as well as various local presentations on the impact of Clinical Pharmacists on patient care.

Currently, she is the Regional Clinical Pharmacist for Life Healthcare, Inland South Division, where she works on the implementation of best practice, improved patient care and outcome while focusing on pharmaceutical treatment options.
Andre Brooks
André Brooks is Head of Clinical Unit and Associate Professor, University of Cape Town, Chris Barnard Division of Cardio-thoracic Surgery, Congenital and Paediatric Cardio-thoracic surgery, Red Cross Children’s and Groote Schuur Hospitals. His training in cardio-thoracic surgery commenced in 1995 at the unit at Port-Elizabeth Provincial Hospital and subsequently at the The Royal Infirmary Edinburgh, Scotland, University of Cape Town’s affiliated Groote Schuur and Red Cross War Memorial Children’s Hospital (RCWMCH). In 2006 he spent a year training at the Birmingham Children’s Hospital, Birmingham, UK.

Dr Brooks has been appointed as a full-time consultant in the division since 2005 and his passion continues to be the development of a surgical programme to suit the specific needs of the African continent. He has established a solid network of world-class international collaboration and with that bringing many innovative surgical strategies to the programme.

During the last two decades he has been instrumental in developing a surgical programme with the philosophy of definitive, biventricular repair whenever feasible. He has significantly expanded the neonatal surgical programme as well as the adult congenital surgical programme. An ECMO programme for paediatric post cardiac surgical patients has been established under his guidance. At RCWMCH in collaboration with the Otolaryngology department an active surgical airway reconstructive programme has been established. Active collaboration with a number of African units have been established. He has been actively involved in overseeing undergraduate student projects and in offering them exposure to the specialty of congenital and paediatric cardio-thoracic surgery.

At present he is an exco member of the Society of Cardio-thoracic Surgeons of South Africa and an examiner for the CMSA. His ideal is to further foster the development of a world-class unit with the therapeutic model of radical definitive repair as best suitable for the African continent.
Stephen Brown
Professor Stephen Brown is the head of Paediatric and Congenital Cardiology, full Professor and senate member of the University of the Free State. He is strongly involved in community outreach in the central South African region. His unit is actively involved in percutaneous interventions and is recognised as a Centre of Excellence for Percutaneous Pulmonary Valve implantation.

He is a NRF C-rated researcher and clinical director of the Robert WM Frater Cardiovascular Research Institute. He has recently been awarded the prestigious council medal of the UFS and has served on various executive committees.
Robert Brozin
Robie Brozin’s proud roots may have been in Middelburg, Mpumalanga, but Robbie Brozin boldly calls himself Jozi-made. It was here he co-founded one of the country’s most loved and successful exports, Nando’s, which today has 1 200 restaurants employing over 35 000 Nandocas in 23 countries around the world. The brand’s success is deeply rooted in the philosophy of having fun while making money, changing the way the world thinks about chicken, and changing lives – one chicken at a time!

After stepping back from his leadership role at Nando’s in 2010, Robbie’s passion for making a difference broadened.

Robbie champions changing lives at Nando’s where the brand partners with Harambee to give young people access to employment. Their various art and design programmes support and develop Southern African creatives and showcase their work in Nando’s restaurants around the world.

With human dignity at the core of Goodbye Malaria, Robbie, and co-founders of this not-for-profit, aim to eradicate malaria in Southern Africa by 2030. In the 2022/23 season alone, 4.5 million people were protected by Goodbye Malaria initiatives against this deadly disease.

In his role as trustee of the South African Constitutional Hill Trust, he focuses on the constitution’s vision of building awareness and knowledge about what the Constitution says.

Through his relationship with the University of the Witwatersrand (WITS), Robbie helps harness the power of digital technology to amplify and secure the future of Chris Hani Baragwanath Academic Hospital (Bara) and the Paediatric Surgical Unit (Surgeons for Little Lives).

With his passion for Johannesburg, and his desire to create hope and optimism, Robbie is part of a movement, called Jozy My Jozi to renovate the city he loves so much.

When not hands-on trying to make Southern Africa and the world a better place, chances are you’ll find Robbie with a frozen vodka in hand, enjoying family time with his wife, three children, grandchildren, and a few mates – all of whom keep him forever young.
Javed Butler (USA)
Professor Javed Butler is the President of the Baylor Scott and White Research Institute, and Senior Vice President and Maxwell A. and Gayle H. Clampitt Endowed Chair at the Baylor Scott and White Health in Dallas, Texas. He is also the Distinguished Professor of Medicine at University of Mississippi in Jackson, MS. Prior to joining Baylor Scott and White Health, he served as the Patrick H. Lehan Chair in Cardiovascular Research, and Professor and Chairman of the Department of Medicine at the University of Mississippi, where he was also Professor of Physiology. Prior to joining the University of Mississippi, he was Charles A. Gargano Professor and Director of the Division of Cardiovascular Medicine and Co-Director of the Heart Institute at Stony Brook University, New York. He had served as the director for heart failure research at Emory University and director of the heart and heart-lung transplant programmes at Vanderbilt University prior to that.

He received his medical degree from the Aga Khan University and then completed residency training at Yale University, cardiology fellowship and advanced heart failure and transplant fellowships at Vanderbilt University, and cardiac imaging fellowship at the Massachusetts General Hospital at the Harvard Medical School. He has completed Master of Public Health degree from Harvard University and a Master in Business Administration from the Emory University.

Dr. Butler is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure. He serves on several national committees for the American College of Cardiology, American Heart Association, National Institutes of Health, and the Heart Failure Society of America. He is the recipient of the Simon Dack Award by the American College of Cardiology as well as the Time, Feeling, and Focus Award by the American Heart Association.

Dr. Butler has authored more than 1000 peer-reviewed publications. He serves on the editorial board of several peer reviewed cardiovascular journals. He has been cited numerous times in America’s Best Doctors list.
Tessica Chetty
Tessica Chetty is the Clinical leader, in GE HealthCare, for the Interventional Portfolio in Sub Saharan Africa. She graduated as a diagnostic radiographer from Durban University of Technology. Tessica also completed the Advanced Diploma in Business Management at Gordons Institute of Business Science.

Tessica underwent training and specialised as an Interventional Radiographer at Sheikh Khalifa Medical Center in Abu Dhabi (UAE) for 6 years. She joined General Electric Healthcare in 2014 as the Clinical Leader for the Interventional and Women’s Health modalities and was responsible for Africa. Currently her primary focus is the Interventional portfolio for Sub Saharan Africa. In her role, some of her responsibilities include developing, co-ordinating, and delivering product training on software and equipment.
Piet Claus
Professor Piet Claus holds a PhD degree in theoretical particle physics from the university of Leuven. After a detour in industry, he returned as a post-doctoral fellow to academia, exploiting his mathematical knowledge and computational skills in the field of cardiovascular imaging and modeling in 2001. He worked initially on echocardiographic deformation imaging and cardiac modelling and was granted two successive mandates as an FWO post-doctoral fellow. He specialised in closed-chest large animal research models for cardiovascular research with a special focus on ischemia and in-vivo characterisation integrating echocardiography, magnetic resonance imaging and nuclear imaging and electrophysiological mapping. He runs and manages the cardiovascular projects on the dedicated experimental magnetic resonance scanner for large animal research at KU Leuven, performing 200 MRI studies/year in different animal models of cardiovascular disease and currently is the academic responsible for the pre-clinical cathlab within the department of cardiovascular sciences. Since October 2014, he was appointed as a tenure track assistant Professor, with research interests experimental magnetic resonance imaging and cardiac mechanics and is appointed Associate Professor wasin 2019. . He is a member of the current department management board (2021-2025), internal KULeuven management boards of the surgical science core facility and the experimental large animal magnetic resonance scanner. Member of the animal welfare body of the department of cardiovascular sciences. He co-authored more than 145 original papers in peer reviewed journals, 65 conference papers and has an h-index of 53 (Scopus) / 64 (Google Scholar). He is the promotor of 4 PhD students and co-promotor of 5 PhD students.
Stephanie Curtis (United Kingdom)
Dr Curtis has been a Consultant Cardiologist in Bristol, UK, since 2008, specialising in congenital heart disease in the adult, inherited cardiac conditions and obstetric cardiology. She is the Clinical Director for the South Wales and South West England Congenital Heart Disease Network and Lead Cardiologist for the South West England Maternal Medicine Network. She is a Fellow of the Royal College of Physicians of London, a Fellow of the European Society of Cardiology and has a Doctorate of Medicine from the University of London.

Dr Curtis is a member of the European Society of Cardiology Working Group for Adult Congenital Heart Disease, the British Society of Echocardiography (accredited in trans-thoracic and transesophageal echocardiography), the British Congenital Cardiac Association, and the UK Maternal Cardiac Society.
Anthony John Dalby
Tony Dalby is a Cardiologist in practice at Life Fourways Hospital in Randburg. He graduated from Pretoria University and did his post-graduate studies at Groote Schuur Hospital and the University of Cape Town. After receiving his F.C.P.(S.A.). he was a Consultant in the Dept. of Cardiology at Johannesburg Hospital for 4 years before entering private practice.

While President of the South African Society of Cardiac Practitioners, he co-founded the SA Heart Association in 1999 and was a member of its Executive Committee until 2011.

He is an Honorary Life Member of the South African Heart Association, a Fellow of the American College of Cardiology and a Fellow of the European Society of Cardiology.

From 1994 until 2016 he served as National Lead Investigator for South Africa on the International Steering Committees of 40 Phase III drug trials in acute coronary syndromes, heart failure, atrial fibrillation, diabetes, and the secondary prevention of atherosclerotic cardiovascular disease.

He has been lead author or co-author of 55 peer-reviewed scientific publications.

He was the Liaising Editor for Africa for the European Heart Journal (2003-2008) and on the editorial board of the Cardiovascular Journal of Africa (1989-2009). He edited Heart Matters, a newsletter distributed to South African cardiologists, physicians and family practitioners, from its inception until 2013. He was a member of the International Medical Advisory Board of MD Conference Express.

He is currently a member of the Board of SA Heart®.
John A. Elefteriades (USA)
Dr Elefteriades is the William W.L. Glenn Professor of Surgery (Cardiothoracic) at Yale University. He completed his undergraduate studies (Physics, French, Psychology) at Yale University and also his medical school, general surgery, and cardiothoracic surgical training were also completed at Yale. Dr. Elefteriades has been on the faculty at Yale for his entire career.

Dr Elefteriades served for many years as the Chief of Cardiothoracic Surgery, until becoming the Founding Director of the Aortic Institute at Yale University, one of the very first such multi-disciplinary clinical and research entities in the country. He has performed nearly 10,000 major cardiac surgeries and has authored of over 600 scientific articles, hundreds of book chapters, and over a dozen textbooks. For the general public, he has written the inspirational book Extraordinary Hearts and the prize-winning medical thriller Transplant, which have been translated into multiple languages. He has lectured and/or operated in 33 countries worldwide.

Dr Elefteriades has received many awards for clinical and scientific work, including an Honorary PhD (for contributions in the field of aortic disease) from the University of Liege (Belgium). He has been designated by expertscape as the “top expert in the world in aortic diseases”. In his off-time, he can be found exercising or occupied with British, Italian, and American sports cars.
Mark E Engel
Professor Engel is based in the SA Cochrane Centre, SA Medical Research Council, as a Chief Specialist Scientist. Initially a medical laboratory scientist, he was later a Harvard University fellow in Public Health in 2001, before pursuing a career in epidemiology. Following completion of his MPH degree, he was awarded a PhD from UCT in 2013 for a large longitudinal study on the epidemiology of RHD in Cape Town children.

Prof Engel networks with African colleagues to apply a wide range of investigative approaches, from molecular to population-based research to all aspects of Rheumatic Heart Disease. In 2016, he established the AFROStrep Study, in efforts to improve the understanding of the role of group A streptococcus in RHD development and inform putative vaccines under development. His work, supported over the years by the SA National Research Foundation, the SA Medical Research Council, the American Heart Association and NIH in the USA, has been presented both nationally and internationally. Recently, Mark managed the RHDGen Study, an Africa-wide initiative to investigate molecular aspects of RHD, reporting novel insights in susceptibility genes and proteomic profiles in RHD. He also teaches health research methods while supervising postgraduate students and is a member of the African Union/PASCAR Education Taskforce and the Burden of Disease Working Group of the Strep A Vaccine Global Consortium (SAVAC).
Barend Fourie
Barend Fourie is a paediatric cardiologist based at Tygerberg hospital and senior lecturer at Stellenbosch University. He has a keen interest in interventional cardiology and advanced cardiac imaging. He recently started a paediatric cardiac magnetic resonance service in the Western Cape after gaining some experience at the Royal Brompton hospital in London.
Alan G Fraser (United Kingdom)
Alan Fraser is Consultant Cardiologist at the University Hospital of Wales, Cardiff, UK; Visiting Professor in Cardiovascular Imaging and Dynamics at the University of Leuven; and Emeritus Professor of Cardiology at the Wales Heart Research Institute, Cardiff University. He qualified in Edinburgh, undertook postgraduate training in Scotland and Wales, and was research fellow at the Thoraxcentre in Rotterdam. He is a Past-President of the European Association of Cardiovascular Imaging, and past Chairman of the Committee on Regulatory Affairs of the European Society of Cardiology. He chairs the Regulatory Affairs Committee of the Biomedical Alliance in Europe and he is Scientific Director of the EU Horizon 2020 CORE-MD project (developing regulatory science for high-risk medical devices) which includes a project on the clinical evaluation of artificial intelligence software for medical devices. His research interests include cardiac imaging, heart valve disease, heart muscle disease, and the pathophysiology and diagnosis of heart failure.
Lebo Gafane-Matemane
Professor Lebo Gafane-Matemane is an Associate Professor of Physiology at North-West University (NWU), Hypertension in Africa Research Team (HART), under the Faculty of Health Sciences, and a visiting scholar at the University of Johannesburg. Her research aims to improve understanding of the patho-physiological mechanisms that lead to hypertension in populations of African ancestry and find innovative ways to improve awareness and treatment. She leads the Translational and Implementation Science sub-theme at HART, which covers clinical trials, validation studies, collaborations with hospitals and clinics on scientific and non-scientific initiatives.

Professor Gafane-Matemane has published more than 50 papers in the field of blood pressure and cardiovascular disease. She is a Fellow of the International Society of Hypertension (ISHF), Japan Society for the Promotion of Science HOPE fellow, a member of the Royal Society of South Africa and holds a Y2 rating from the National Research Foundation. Professor Gafane-Matemane is one of the executive directors of the Childhood Hypertension Consortium of South Africa and a board member of the Southern African Hypertension Society. She serves on the NWU Health Research Ethics Committee, the International Society of Hypertension Mentorship and Training Committee and the South African National Committee for the International Union for Physiological Sciences. She is on the editorial boards of the Journal of Hypertension and Journal of the American Heart Association.
Babar S. Hasan (Pakistan)
Professor Hasan, Diplomate American Board of Pediatrics and Pediatric Cardiology.

Undergraduate from The Aga Khan University Karachi, Pakistan. Pediatric residence from Riley Hospital for Children, followed by fellowship in general pediatric cardiology, advanced imaging and interventional cardiology from Boston Children, Harvard Medical School.

Professor Hasan’s research interests are CHD care delivery in low-resource settings, quality improvement specifically creating congenital cardiac cath database for low to middle income countries, use of artificial intelligence for task-sharing, pulmonary hypertension in low-resource setting and thalassemia cardiomyopathy. He is currently Chair and Professor, Division of Cardiothoracic Sciences, Sindh Institute of Urology and Transplantation (SIUT), Karachi, Pakistan.
Samkelo Jiyana
Dr Jiyana is a paediatric cardiologist in private practice and public practice it the city of Gqeberha in the Eastern Cape. His interests are cardiac intensive care, interventional paediatric cardiology and grown up congenital heart disease. He trained his paediatric cardiology at Dora Nginza Hospital under the late Prof Pepeta and Dr Adele Greyling.

He has published papers focusing on PDA closure in low-birth weight infants, grown up congenital heart disease in the Adole 7C study and is currently leading the paediatric arm of the Imhotep study in Gqeberha. He loves travelling and when he’s at home relaxing with his yorkies.
Paul Knaapen (Netherlands)
Professor Paul Knaapen is an Interventional Cardiologist, the Director of Cardiac PET/CT and a Professor of Interventional Cardiology at Amsterdam UMC, Netherlands. Prof. Knaapen received his M.D. from the VU University School of Medicine. He then completed his internship, residency, and interventional cardiology fellowship at the VU University Medical Center.

Prof. Knaapen is Professor of Cardiac Intervention and Imaging, Division of Cardiology at the VU University Medical Center, where his major research interest is the clinical value of non‐invasive cardiac imaging, with a particular focus on hybrid PET/CT and chronic total occlusions (CTOs).

As a clinical researcher, he has co-authored 223 peer-reviewed articles and participated in 7 clinical trials over the past 15 years. He lectures both nationally and internationally on cardiac PET/CT imaging and complex coronary interventions with an emphasis on CTOs.
Sarah Kraus (UK)
Dr Sarah Kraus completed her undergraduate and postgraduate training at the University of Cape Town (UCT), graduating as a Fellow of the College of Physicians of South Africa in 2013. She was awarded the Helen and Morris Mauerberger Scholarship in 2014 and completed her PhD at UCT in 2019. Her doctoral work focused on the establishment of the African Cardiomyopathy and Myocarditis Registry Programme (IMHOTEP), a prospective multi-centred clinical registry and DNA repository designed to facilitate cardiomyopathy and genetics research in Africa. In 2017, she and her colleagues were awarded the NRF Team Science Award for the discovery of the CDH2 gene, a novel cause of Arrhythmogenic Cardiomyopathy.

Sarah is a specialist in internal medicine, with expertise in the cardiomyopathies, heart failure, inherited cardiac conditions, and cardiovascular magnetic resonance. After completing her PhD in Medicine, Sarah went abroad to do a postdoctoral fellowship in cardiovascular genetics at the University of Oxford, while completing the Postgraduate Course in Heart Failure in London (Zurich/London Heart House, Royal Brompton & Harefield). She was awarded the UCT FHS Postdoctoral Fellowship Award in 2022 in support of her genetics research. While abroad, Sarah has continued her role as the senior clinical researcher of the IMHOTEP study (UCT) and is an honorary consultant in the Department of Medicine at Groote Schuur Hospital (GSH). In 2023, she launched the Inherited Cardiomyopathy Genetic Counselling and Family Screening Initiative at GSH, a programme that facilitates results feedback, counselling and family screening to individuals with cardiomyopathy-causing gene mutations identified through the IMHOTEP study. She is affiliated with the SAMRC Extramural Unit on Intersection of Noncommunicable and Infectious Diseases, the Cardiovascular Genetics Laboratory at the Cape Heart Institute (UCT), the Cape Universities Body Imaging Centre, the World Heart Federation Emerging Leaders Programme. She recently joined Global Heart as a deputy editor.
Ruan Kruger
Ruan Kruger is a Professor of Physiology in the Faculty of Health Sciences at the North-West University with a research focus on hypertension in children and early adulthood. He is the sub-theme Lead in Epidemiology and Preventive Science of the Hypertension in Africa Research Team (HART), a centre of excellence at the North-West University.

He is the President of the Childhood Hypertension Consortium in South Africa (CHCSA), the Chair of the Next Generation Committee of the Southern African Hypertension Society (SAHS) and holds fellowship (ISHF) status with the International Society of Hypertension (ISH). He held the DSI-NRF South African Research Chair (SARChI) in the Early Detection and Prevention of Cardiovascular Disease in Africa. He serves on several institutional as well as national and international committees including the International Congress on Hypertension in Children and Adolescents (ICHCA), the International Pediatric Hypertension Association (IPHA) and the ISH.

He further holds several professional memberships from SA Heart ® , the European Society of Cardiology (ESC), the ISH, SAHS, American Physiology Society (APS) and the International Society of Nephrology (ISN). He has published >100 research outputs in international peer-reviewed journals and supervised >50 postgraduate students and postdoctoral fellows. He is the Principal Investigator of the Arterial Stiffness in Offspring Study (ASOS) as well as the Swiss-collaborative Exercise, Arterial Modulation and Nutrition in Youth South Africa (ExAMIN Youth SA) study and attracted numerous research grants, and established multiple national and international collaborative networks with prestigious universities, organisations and consortia.
Lervasen Pillay
Dr Lervasen Pillay qualified with an MBChB from UP and MSc(Med)Sports Medicine from Wits, he has 3 private sports and exercise medicine practices around Johannesburg (Sandton Sports Medicine, Mediworx-s and Constantia Kloof Sports and Exercise Medicine) where he cares for different levels of athletes in Football, Cricket, Rugby, Gymnastics, horse-riders and Athletics for over 18 years.

He is presently a PhD candidate regarding male football player health surveillance in the international football environment done jointly with the University of Amsterdam and University of Pretoria. Other involvement includes being a post-graduate lecturer, examiner, supervisor and researcher at Wits (WiSH and CESSM) and University of Pretoria for Honours and Masters students, the Therapeutic Use Exemption Commission Chairperson at South African Institute for Drug Free Sport (SAIDS), a SASCOC accredited provider, a preferred provider for Wits Sport and the CMO for Events Medical Consulting.

Dr Pillay is also serves on the Exo of the South African Sports Medicine Association. Previously he was the SA CMO at World Champs Daegu 2011, Africa Champs Benin 2012, AUSC games Angola 2016, Bidvestwits FC head of medical (2007-2017), Orlando Pirates team doctor (2017-2020), Pro-touch cycling team doctor (2017-2022), PSL CMO (2020-2022 – developing the return to football guidelines with COVID19), PSL Medical group secretary and Doping Control Officer for the 2009 Confederations Cup at Loftus, Central Gauteng Lions head of Medical (2015 to 2022).

Dr Pillay is and has been involved in several educational CPD series with Wits Institute for Sport Health (WiSH), private institutions, societies and has attended and presented at several local and international conferences, television and radio interviews on several sports and exercise medicine related issues over the last 19 years. He has authored and co-authored several sports and exercise medicine related publications and position statements in peer-reviewed journals. He is a terrible golfer and an even worst guitar player.
Renato D. Lopes
Dr Lopes is a professor in the Department of Medicine of the Division of Cardiology at Duke University Medical Center, in Durham, North Carolina. He is director of Clinical Events Classification (CEC) and the co-director of the Integrated Clinical Events—Safety Surveillance Group at the Duke Clinical Research Institute.

Dr Lopes has an interest in novel antithrombotic therapies for the management of patients with atrial fibrillation and acute coronary syndromes as well as in the discovery of new cardiology biomarkers. He has led several national and international clinical trials and registries. He has also participated in more than 127 clinical events committees (CECs) for many important clinical trials, serving as CEC chair and/or principal investigator for many of them.

Dr Lopes has delivered more than 500 international lectures, authored or co-authored more than 570 peer-reviewed articles and 30 book sections, and has authored 8 books.
Thomas F. Lüscher (Switzerland)
Professor Lüscher studied medicine at the University of Zurich and obtained board certification in internal medicine and cardiology in Switzerland and is GMC certifified in the UK.

He trained at the Mayo Clinic in Rochester, MN, USA in cardiovascular physiology and cardiology and was Professor of Pharmacotherapy and Director of Clinical Pharmacology at the University Hospitals Basel, then Professor and Vice-Chairman of Cardiology at the University Hospital Bern and later Professor and Chairman of Cardiology and Director of the University Heart Center at the University Hospital Zurich, Switzerland.

Since 2017, he is Director of Research, Education & Development and Consultant cardiologist at the Royal Brompton & Harefield Hospitals and Professor of cardiology at the Imperial College and Kings College in London, UK. He also holds a part-time commitment as Chairman of the Center for Molecular Cardiology at the University of Zurich (see

Professor Lüscher has been mentoring numerous physicians and scientists from around the world with many holding chairs or directorships at universities and major hospitals in Switzerland, Europe, Asia and North America.

His research is translational from bench to bedside and focuses on endothelium-derived mediators and their alteration with aging, hypertension, lipids and inflammation as well as on atherosclerosis, coronary artery disease, acute coronary syndromes and heart failure. He is among the 0.1% most cited scientists with a h-index of 151 (Research Gate).

He is an editor of the ESC Textbook of Cardiovascular Medicine (Oxford University Press 2019) and the Module Innere Medizin (Springer Verlag, Heidelberg, FRG) and of the Manual of Cardiovascular Medicine (Oxford University Press 2022). He lectures worldwide and is director of the Zurich Heart House with its educational programme (Postgraduate Course on Heart Failure London, London Shock, Cardiology Update London, MasterClasses in Heart Failure worldwide, Webinars) He is also active on social media ( and has his own youtube channel ( He was editor-in-chief of the European Heart Journal 2009-2020 (increase in IF from 8.9 to 29.9) and continues as senior editor. He is now president elect of the European Society of Cardiology.
Luc Maillard (France)
Dr. Luc MAILLARD is an interventional cardiologist working South of France in Aix en Provence with over 30 years of experience. He reported one of the first studies of stent thrombosis in acute MI in 1995. He worked work with Jeff ISNER and Ken WALSH and reported the apoptosis phenomenon in the cardiovascular system, as well the re-endotheliasation process in stented arteries.
Hlombe Makuluma
Dr Makuluma is a qualified general medical practitioner with a Masters in Medical Law and Ethics from the University of Pretoria. He has more than 20 years’ experience in the health industry from operating his own private practice and working for various corporates to health consulting.

At EthiQal, he provides medico-legal advice on various issues affecting the doctor, from general advice through to claims, complaints and notifications. He is the interface between the doctor and legal and risk management processes.

When not busy with work-related matters, he explores various mountain bike trails with his mountain bike. He has finished a couple of Cape Cycle Tours and 94.7 Cycle Challenges.
George McDaniel (USA)
Dr George McDaniel is an Associate Professor of Pediatrics and Internal Medicine at the University of Virginia in Charlottesville, Virginia, USA. His primary practice is management of dysrhythmia in pediatric patients and adult patients with congenital heart disease. He is Board Certified by the American Board of Pediatrics, American Board of Internal Medicine, and international Board of Heart Rhythm Examiners. He has taught and performed electrophysiology cases in South Africa at the Chris Hani Baragwanath Hospital along with Dr. Adele Greyling. He is a past speaker on pediatric topics at the South African Heart Congress and Cardiac Arrhythmia Society of Southern Africa Annual Symposium.
James K. Min
James K. Min is currently the Founder and CEO of Cleerly, a digital healthcare company whose mission is to create a world without heart attacks. Min is a former Professor of Radiology and Medicine at Weill Cornell Medical College and the Director of the Dalio Institute of Cardiovascular Imaging (ICI) at NewYork-Presbyterian. He is a board-certified cardiologist with a clinical focus on cardiovascular disease prevention and cardiovascular imaging.

With a clinical and research focus on coronary artery disease, Min has published more than 550 peer-reviewed manuscripts that have been funded, in part, by numerous grants awarded by the National Institutes of Health and the Dalio Foundation. Min has served as Principal Investigator on numerous landmark multi-centre clinical trials and registries, including the Accuracy, Confirm, Conserve, Iconic and Paradigm trials.. Min is also the director of a state-of-the-art core laboratory for coronary computed tomography for several multicenter clinical trials, including for the Pacific and Ischemia trials.

Min is Past-President of the Society of Cardiovascular Computed Tomography (SCCT), where he served as Chair for the Annual Scientific Sessions meeting for 5 years. He was the 2017 recipient of the SCCT Gold Medal Award for lifetime achievement in the field of CT. He served as a leader in the American College of Cardiology where he has served on the Task Force for Clinical Expert Consensus Documents and the Task Force for Appropriate Use Criteria. Min served as Editor-in-Chief of the Journal of Cardiovascular Computed Tomography, Associate Editor for the Journal of the American College of Cardiology: Cardiovascular Imaging, Associate Editor of the Journal of Nuclear Cardiology, and on the Editorial Board of Circulation: Cardiovascular Imaging. Min has received numerous awards and distinctions, including recently being inducted into the American Society of Clinical Investigation and the Academy of Radiology Research.

For Min, the development, validation and dissemination of Cleerly’s products and services offer him an opportunity to translate the large-scale clinical trial research he has spent doing in the last 20 years into daily clinical practice through innovative solutions in coronary heart disease that have not existed in the marketplace to date.

Min received his BA from the University of Chicago, and his medical degree from Temple University Medical School. He completed his internship, residency and cardiovascular medicine fellowship at the University of Chicago Hospitals.
Martin Mpe
Dr Martin Mpe works as a private cardiologist at Mediclinic Heart Hospital in Pretoria and Netcare Pholoso Hospital in Polokwane. He is also a session cardiologist and acting HOD of the Heart Unit at No. 1 Military Hospital in Thaba-Tshwane where he assists in interventional cardiology and cardiac pacing, including cardiac resynchronization therapy and ICD implants.

Dr Mpe is a member/chair of the Board of SA Heart Association, Chairperson of the Social and Ethics Committee of the SA Heart Board, immediate past-President of the Heart Failure Society of South Africa. He is an advisory board member and immediate past-President of the SA Hypertension Society and previous member and past Chairperson of the Aero-Medical Committee of the SA Civil Aviation Authority.
Richard Nethononda
Professor Nethonda’s current position: Head of the Division of Cardiology at Chris Hani Baragwanath Academic Hospital and Associate Professor in the Faculty of Health Sciences of the University of the Witwatersrand. The division of Cardiology at Chris Hani Baragwanath Academic Hospital is the largest in South Africa with a catchment area that include Southern Gauteng, parts of the Eastern Gauteng and the Northwest Province.

He qualified as a Cardiologist in 1999 from the University of the Witwatersrand, Johannesburg, South Africa and went on to study for a DPhil degree at the University of Oxford (2005-2009). His main research interesst are cardiovascular imaging using Cardiac MRI, heart muscle conditions, aortic conditions, coronary artery diseases and cardiac conditions in pregnancy. In addition, Professor Nethononda has vast clinical experience in the management of many cardiovascular conditions including rheumatic valvular diseases, other structural heart disease, acute coronary syndromes. He is also highly skilled in echocardiography and cardiac catheterisation in the management of both acute and chronic cardiovascular conditions.
Ntobeko Ntusi
Professor Ntusi is the Head of Medicine and the Clinical Lead for Cardiovascular Magnetic Resonance (CMR) and Cardiovascular Computed Tomography (CCT) at Groote Schuur Hospital and is appointed as a Cardiologist, Professor and Chair of Medicine in the Department of Medicine in the Faculty of Health Sciences at the University of Cape Town (UCT).

His primary research interests comprise inflammatory heart disease (including HIV-associated cardiovascular disease), non-ischaemic cardiomyopathy and non-invasive imaging, in particular with CMR. He has in-depth training and expertise in CMR and CCT. Professor Ntusi has extensive experience with basic science, translational and clinical research. He currently supervises postgraduate students and is conducting several single-centre mechanistic clinical studies, which are mostly CMR-based.

Through his research, Professor Ntusi has built strong links with colleagues in clinical cardiology, physics and biomedical engineering, tuberculosis and HIV medicine, rheumatology, immunology, molecular genetics, and biomedical statistics; and he has shown capacity for performance in scientific investigational teams and is suited to being part of multi-disciplinary and multi-centre clinical studies.

The current application builds logically on his work on CMR in HIV-associated heart disease. He obtained a BSc (Hons) degree in Cellular and Molecular Biology from Haverford College, USA, and an MBChB degree from UCT, before completing a fellowship in Internal Medicine through the Colleges of Medicine of South Africa. He served his internship and later worked as a community service medical officer and senior house officer at Frere Hospital in East London, South Africa. He read for a DPhil in Cardiovascular Medicine at the University of Oxford and completed his MD in Cardiology at UCT. He is a qualified cardiologist, through the Colleges of Medicine of South Africa. He has been actively engaged and has contributed to improved understanding of cardiomyopathy, inflammatory heart disease and heart failure in South Africa and abroad.

Professor Ntusi is the holder of various awards and honours and has published widely.
Fathima Paruk
Fathima Paruk is full Professor of Critical Care. She is the Academic and Clinical Head of the Department of Critical Care at the University of Pretoria and Steve Biko Academic Hospital in South Africa(SA). She is the President of the Critical Care Society of Southern Africa(CCSSA) and an elected member of the Council of the World Federation of Intensive and Critical Care Medicine. Additionally, she holds various positions including Co-Chair of the Africa Telehealth Collaboration, Chair of the Critical Care College Committee in the Colleges of Medicine of SA and membership of the Human Research Ethics Committee of the University of Witwatersrand.

Professor Paruk has served on several Ministerial appointed committees including the National Health Research Committee and the Committee for the Confidential Enquiry into Maternal Deaths in SA; and more recently serves on the HPCSA. Her interests include telehealth, critical care obstetrics, sepsis, drug dosing, biomarkers, critical care training and medical ethics. She has also successfully trained many intensivists and supervised many postgraduate degrees including PhDs. Professor Paruk has authored numerous guidelines, book chapters, reviews and research publications and is regularly invited as a speaker at various national and international platforms.
Jane Pilusa
Jane Pilusa is a Paediatric Cardiologist and completed her medical training at the University of Pretoria, having completed her undergraduate training (MBChB) in 2006. Prior to returning to the University of Pretoria to commence with Paediatric training, she obtained the diploma in HIV Management - DipHIVMan(SA) as well as a diploma in child health -DCH (SA). After completing her Paediatric training in 2016 she further qualified with a FCPaed(SA) followed by an MMed Paed.

Paediatric Cardiology training then followed where she obtained both the certificate in Cardiology - Cert Cardio (SA) and an MPhil in Paediatric Cardiology (SA).

Her area of special interest is to identify every child with cardiac disease early, so that surgical intervention is done timeously without the added risk of pulmonary hypertension in the relevant cardiac conditions, so that each and every child gets a chance at living a normal life, without the added morbidity of an unoperated or undiagnosed heart problem.

Acknowledging that we can’t save all children with congenital heart disease (CHD), My motto therefore is: “May we diagnose ALL children with CHD, May we save MOST children with CHD”
Frederick J. Raal
Professor Derick Raal is a Distinguished Professor and Director of the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, at the University of the Witwatersrand. After obtaining his MBBCh degree cum laude in 1981, he obtained his Master of Medicine in 1991, his PhD in 2000 and his Doctor of Science in 2022. He has received numerous postgraduate awards including the TH Bothwell Research Prize, the FJ Milne award, and the Vice Chancellor’s Research Award. He is a NRF A-rated scientist, is recognised as a Web of Science highly cited researcher, and has authored or co-authored over 350 original articles and book chapters. He is particularly interested in lipid disorders and has been integrally involved in the management of familial hypercholesterolaemia (FH). The major focus of his research remains the clinical, biochemical, genetic and therapeutic management of this condition and he continues to conduct studies with novel therapies such as ANGPTL3-inhibitors in this patient group.
Darshan Reddy
Dr Reddy is a cardiothoracic surgeon practicing at the Lenmed Ethekwini Hospital and Heart Centre in Durban.

  Dr Reddy completed his undergraduate medical degree at the University of Cape Town (UCT) and his cardiothoracic surgical training at the University of Kwazulu Natal (UKZN), completing both a Masters in Medicine and the Fellowship of the Colleges of Cardiothoracic Surgeons of South Africa. Dr Reddy spent a year as a visiting clinical lecturer in Pediatric Cardiac Surgery at the University of Michigan, USA and has a special interest in the surgical treatment of paediatric and congenital heart disease.

Dr Reddy holds leadership positions in the Society of Thoracic Surgeons (STS), the World Society of Pediatric and Congenital Heart Surgery (WSPCHS), and the African Society of Pediatric and Congenital Heart Surgery (ASPCHS).  His interests include complex neonatal cardiac surgery and rheumatic mitral valve repair.
Pieter-Paul Strauss Robbertse
Dr Robbertse is a researcher-clinician that strives to improve the understanding of cardiovascular related issues in a resource constrained South Africa. He completed his MBChB degree cum laude at Stellenbosch University in 2015 and my PhD on HIV-associated cardiovascular disease in 2022.

Dr Robbertse’s interest in cardiology and diagnostics have been combined with pressing HIV-related questions. He is currently hosted as a post-doctoral fellow at The Division of Cardiology, Tygerberg Hospital where he is involved with cardiovascular disease research in a high HIV-burden setting. Following completion of a cardiovascular magnetic resonance imaging (CMR)-fellowship at Tygerberg Hospital, he was certified by the European Association of Cardiovascular Imaging (EACVI) as a level II CMR physician.

Dr Robbertse is involved with the reporting of CMR-examinations for clinical practice also he is actively engaged in CMR training and education. His hopes are to expand local CMR expertise and capacity to ultimately improve patient care.
Suriah Salam
Suriah Salam is aa registered nurse with 13 years Cardiac Catheterisation Laboratory experience. She qualified with a Bachelor’s degree in Nursing, (Midwifery, Community Health and Mental Health) from University of Kwa Zulu Natal in 2007.

Her community service was completed at Dundee Provincial Hospital in 2008. Suriah has worked in the Kingdom of Saudi Arabia at National Guard King Abdul Aziz in Jeddah from 2012.

Previously, Suriah worked at Life Healthcare Westville Hospital were she successfully completed the Mentorship to unit manager and am currently at Netcare St Augustine’s Cardiac Cath Lab.

Suriah is an ICAP member and has presented at a number of ISCP webinars.
Chris Scott
Chris Scott is Professor and former head of Paediatric Rheumatology at Red Cross War Memorial Children’s Hospital and the University of Cape Town. He is currently director of the Clinical Research Centre at UCT. Professor Scott is a PI on multiple clinical trials in addition to leading a multi-disciplinary team of specialised clinical trial staff working on clinical trials for a wide array of medical disciplines.

His research and educational focus are on the care of patients with rare and rheumatic diseases in Africa and other less resourced communities. Professor Scott has a special interest in access to care, Paediatric Vasculitis, SLE, Juvenile Idiopathic Arthritis and Fibrodysplasia Ossificans Progressiva.

He is a former the chairman of the South African Arthritis Foundation and the co-chair of the Global Task Force for Musculoskeletal Health Task Force. He also serves on the Steering committee of the Paediatric Society of the African League of Associations for Rheumatology. He is Chairperson of International Clinical Council for FOP.
Jacque Scherman
Professor Scherman obtained his MBChB degree (“Doctor of Medicine”) from the University of Pretoria, followed by a Diploma in Occupational Medicine (cum laude) from the University of Stellenbosch. After being awarded the Fellowship in Cardiothoracic Surgery from the Colleges of Medicine of South Africa (FC Cardio (SA)), he was registered as a specialist cardiothoracic surgeon in South Africa. He further completed a Masters degree in Cardiothoracic Surgery (thesis awarded cum laude) at the University of Cape Town, South Africa.

He completed his general surgical training whilst serving in the South African Military Services, and then joined the Chris Barnard Division of Cardiothoracic Surgery in Cape Town. He proceeded to further his training in minimally invasive cardiac surgery and catheter based heart valve interventions, being appointed as full time staff surgeon at the University Hospital of Zurich in Switzerland.

Professor Scherman is currently serving as the Head of the Clinical Unit in the Chris Barnard Division of Cardiothoracic Surgery at Groote Schuur Hospital, Cape Town. His niche area of expertise and current research focuses on less-invasive surgical and catheter-based solutions for structural heart valve disease. He established and heads the largest university hospital based minimally invasive cardiac surgical programme in South Africa and also the first university based transcatheter aortic valve insertion (TAVI) programme in the country, serving as co-Principal Investigator for the national South African TAVI registry.
Karin Sipido
Karin Sipido is Professor and Head of Experimental Cardiology at the Department of Cardiovascular Sciences, KU Leuven. Her research field is rhythm disturbances and heart failure, identifying cellular and molecular mechanisms, in a translational perspective. Her expertise is in cellular electrophysiology and calcium imaging of isolated cells and tissues, using living cardiac myocytes and fibroblasts, isolated from animal models and human hearts. Molecular studies of gene expression and regulation underpin the functional studies. Her research is in close collaboration with imaging specialists and clinical electrophysiology. She is an elected member of the Academia Europaea, and elected Fellow of the European Society of Cardiology, of the American Heart Association and of the International Society for Heart Research. She has held several editorial positions.

She takes an active interest in research policy, serving in various positions at KU Leuven, at European and international level. She was member of the board of the European Society of Cardiology, and led the Council for Basic Cardiovascular Sciences. She was a founding member and President of the Biomedical Alliance in Europe. From 2015-2020 she chaired the European Commission’s Scientific Panel for Health (SPH), a science-led expert group based on the provisions of Horizon 2020. She is a member of the Scientific Advisory Board of ORE, the European Commission’s Open Research Platform.
Jan-Peter Smedema
Dr Jan-Peter Smedma obtained his MB ChB in Amsterdam (1989) and trained in Internal Medicine and Cardiology at Stellenbosch University and the Erasmus Medical Centre (Rotterdam). He obtained additional qualifications in CMR (Royal Brompton Hospital) and Stroke Medicine (ESO) and has been working as a general and interventional cardiologist in-private-practice with the Netcare Hospital Group since 2005.

He completed his PhD in 2019 (The diagnostic and prognostic value of CMR in cardiac sarcoidosis, Maastricht University) and is currently completing his MPhil in Sports & Exercise Medicine (UCT). He is actively involved in clinical cardiovascular research of both able-bodied and paraplegic endurance athletes and is also the founder of the Sport Cardiovascular Research Programme. This programme is focused on sport cardiology: preparticipation screening, clinical care and original research of cardiovascular (mal) adaptations in South African athletes.
Hans Strijdom
Professor Hans Strijdom is a clinician-turned-academic, and currently Professor and Head of the Division of Medical Physiology and Deputy Director of the Centre for Cardio-metabolic Research in Africa at Stellenbosch University. His broader research focuses on the physiology and pathophysiology of the cardiovascular system, with a particular interest in vascular and endothelial biology. Whilst initially conducting mainly laboratory, cell, tissue and organ-based research, he has since 2015 shifted to clinical research. In 2015 he was awarded funding via the ERAfrica programme (EU FP7) and became the project co-ordinator of the EndoAfrica study consortium that included researchers from South Africa, Austria and Belgium. The EndoAfrica study investigated vascular endothelial changes in people living with HIV (PLWH) and people exposed to air pollution. For the past number of years, he has published extensively on the interaction between HIV and cardio-metabolic changes in PLWH.

Professor Strijdom recently received grants from the NIH and NRF for a study that will explore mitochondrial function in PLWH with and without cardiometabolic disease in South Africa and Kenya. Hans, a C2-rated scientist with the NRF, has published 54 peer-reviewed articles and presented over 80 papers at national or international scientific meetings, including 13 as an invited speaker. He has supervised 17 doctoral candidates, 19 Master candidates and hosted 7 post-doctoral fellows. Apart from his research activities, Hans is a full-time lecturer in postgraduate and undergraduate human physiology for the MBChB, BSc Physiotherapy, BSc Dietetics, B Nursing and B Occupational Therapy programmes. He has won several general performance (research, teaching and service) and undergraduate teaching awards in the Faculty and University.
Martin Sussman
Dr Martin Sussman qualified at the University of the Witwatersrand Johannesburg South Africa in 1982, (Cardiothoracic Surgery) 1990, South African College of Medicine Clinical Fellow Cleveland Clinic Foundation 1992/3 . Michael and Janie Miller Foundation Fellowship in Surgery, New York University 1997 and Consultant, Johannesburg Hospital until 1999.

He is currently a Consultant Surgeon in private practice at Milpark Hospital Johannesburg South Africa.

Dr Sussman is a member of the South African Heart Association, Past-President (2010/2011), South African Society of Cardiothoracic Surgeons, The South African Medical Association, South African Thoracic Society and the American College of Cardiology.
Justiaan Swanevelder
Dr Swanevelder is a UCT Professor and Head of Department at the University of Cape Town, Groote Schuur Hospital. His areas of interest are; Adult and Paediatric Cardiothoracic Anaesthesia and Critical Care, and influence of Echocardiography and medical ultrasound on perioperative patient outcome. Valvular heart disease, especially Rheumatic Heart Disease, and the failing ventricle post-cardiopulmonary bypass. Congenital heart disease and influence of perioperative echocardiography on patient outcome. Value and safety of Point of Care Medical Ultrasound in Critically Ill Patients in the Developing World. Introducing a fair, inclusive Perioperative Medicine Programme to South Africa, and Sub-Saharan Africa.

Professor Swanevelder is widely published in 80 publications.
Edwin W. Turton
Professor Turton is currently head of the department of Anaesthesiology at the University of the Free State and the Bloemfontein hospitals complex, South Africa.

Previously he worked as head of the clinical unit, cardiothoracic anaesthesia- University of the Free State and Bloemfontein hospital and as co-director and head of the clinical unit, adult cardiac anaesthesia at the Heart Centre in Leipzig, Germany).

Professor Turton’s clinical interests include adult and paediatric cardiac anaesthesia and his wish is: Affordable wearable wireless appropriate monitoring (AWWAM) for all patients in the perioperative setting.
Michael Urban
Professor Michael Urban is employed as principal pathologist and Head of Clinical Services at the Division of Human Genetics, National Health Laboratory Service and University of the Witwatersrand.

Professor Urban’s alma mater for his medical degree is primary speciality in paediatrics and sub-specialist qualification in medical genetics. Prior to sub-specialising he practised in neonatology and general paediatrics for six years at Chris Hani Baragwanath and Rahima Moosa Hospitals. Thereafter he worked as a medical geneticist in Cape Town and proud to have developed a fully-fledged Clinical Unit of Medical Genetics and Genetic Counselling at Tygerberg Hospital, where he practiced for over a decade.

Michael has a particular interest in prenatal and perinatal care of genetic and other congenital disorders, and accordingly my PhD in Health Sciences was on the topic of fetal alcohol syndrome. He has published over fifty articles on various aspects of medical genetics and perinatal care and holds an associate professorship (extraordinary) from the University of Stellenbosch.
Kim de Vasconcellos
Dr de Vasconcellos is an Intensivist based at King Edward VIII Hospital in Durban and affiliated with the Department of Anaesthesiology and Critical Care at the University of KwaZulu-Natal.

Honorary secretary of the Critical Care Society of Southern Africa. Passion for furthering evidence-based, cost-effective, high quality critical care in South Africa.

Examiner: Part I examination in anaesthesiology, with focus on pharmacology. Research interests include inotropic support and outcome in critically ill patients.
Vijay Mammen
Dr Mammen is a Paediatric Cardiologist at Chris Hani Baragwanath Academic Hospital in Soweto, Johannesburg. He is also a lecturer in the Department of Paediatrics and Child Health at Wits University.

He completed his undergraduate training at Wits University in 2007. He also completed his Diploma in Child Health in 2010. He then completed his Fellowship in Paediatrics in 2014 and has a MMED in Paediatrics from Wits University (2015). He completed his fellowship in Paediatric Cardiology in 2019 at Chris Hani Baragwanath Academic Hospital. He has a keen interest in all aspects of Paediatric Cardiology, including interventional cardiology.
Shoyab Wadee
Dr Shoyab Wadee is a full-time nephrologist in private practice in Johannesburg. He is an active member of the transplant community in Johannesburg and cares for patients with kidney, liver and combined transplants.

Dr Wadee has more than 15 years of experience in various spheres of nephrology including kidney transplantation and is the current President of the South African Renal Society. He is an ex-officio member of the SA Transplantation Society Exco.

He is passionate about improving access to care for patients with kidney disease and broadening access to transplantion.
Rik Willems
Professor Willems obtained his PhD in medical sciences on the topic “Mechanisms of remodellming underlying atrial fibrillation” in 2005 under the supervision of H. Heidbuchel and K.R. Sipido. After a clinical fellowship in cardiac electrophysiology at the Foothills Medical Center, University of Calgary, Canada, he was appointed staff at the Cardiology Division of UZ Leuven, where he is currently responsible for the non-invasive cardiology unit and the clinical cardiac electrophysiology unit.

In his clinical work, he is mainly focused on device therapy for cardiac arrhythmia. He actively participates as a researcher in the division of Experimental Cardiology of the Department of Cardiovascular Science and is appointed professor at the KU Leuven. His research is focused on the non-invasive risk prediction of sudden cardiac death and the pathophysiology of atrial fibrillation. He is supported as a clinical researcher by the Fund for Scientific Research Flanders since 2010. He is co-author of more than 230 scientific publications (web of science H-index 37) and principal investigator of several academic studies and studies sponsored by the pharmaceutical industry.
Seth J. Worley (USA)
Professor Worley, Fellowship in Cardiology, Assistant Professor of Medicine, Duke University, Senior Consultant, Assistant Professor of Medicine, Mayo Clinic, from 1987-2017. Director of Electrophysiology, Research, Heart and Vascular Institute Lancaster PA. Developed and patented a set of tools for LV lead implantation.

Professor Worley pioneered the use of subclavian venoplasty, coronary venoplasty, snares and other interventional techniques for device implantation. Director of the Lancaster Interventional Advanced Device Implantation Program.

Currently, Senior Consultant for Cardiac Rhythm Device Management, Director of the Interventional Implant Program, MedStar Heart and Vascular Institute, Washington Hospital Center, Washington, DC.

Professor Worley’s principal focus is on teaching ‘an interventional approach to device implantation’, utilising a set of tools and techniques to reduce implant time, improve lead position despite difficult anatomy and eliminate surgical epicardial leads.
Azfar Zaman
Professor Zaman is a Consultant interventional cardiologist at Newcastle’s Freeman Hospital specialising in ischaemic heart disease, aortic stenosis and diabetes associated coronary heart disease. He is also an Honorary Clinical Professor of Cardiology at Newcastle University. Professor Zaman joined the Newcastle Hospitals in 2001 and was awarded Honorary Professor of Cardiology by Newcastle University in 2013.

Following graduation at Leeds Medical School, Professor Zaman completed postgraduate training in cardiology at regional centres in Leeds, London and Cardiff. He was a Fulbright Scholar and British Heart Foundation International Fellow in 1998 to study vascular biology at Mount Sinai Medical Center, New York. He is the Clinical Lead for Coronary Intervention and Director of the Cardiac Catheter Laboratories. In 2012 he was also appointed Specialty Group Lead for Cardiovascular Research and has an interest in clinical research with a particular interest in atherothrombosis in diabetes and clinical trials.

For more information, please contact

Visit the SA Heart Association